Thornburg Investment Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
18,413
-19,924
-52% -$2.41M 0.02% 119
2026
Q1
$6.27M Buy
38,337
+366
+1% +$56.3K 0.07% 101
2025
Q4
$6.61M Sell
37,971
-6,077
-14% -$1.11M 0.08% 110
2025
Q3
$6.34M Sell
44,048
-9,200
-17% -$1.13M 0.08% 111
2025
Q2
$5.36M Sell
53,248
-15,592
-23% -$1.19M 0.07% 125
2025
Q1
$5.25M Sell
68,840
-5,909
-8% -$452K 0.07% 126
2024
Q4
$5.16M Sell
74,749
-1,120
-1% -$80.7K 0.07% 138
2024
Q3
$5.54M Buy
+75,869
New +$5.6M 0.07% 145

Other funds holding INSM

Thornburg Investment Management's INSM Position: Q2 2026 in Review

Thornburg Investment Management reduced its Insmed (INSM) stake by 52% in Q2 2026, selling an estimated $2.41M and leaving 18,413 shares worth $1.96M. The position accounts for 0.02% of the portfolio, ranked #119.

Thornburg Investment Management first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.61M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Thornburg Investment Management held 18,413 shares of Insmed worth $1.96M as of Q2 2026.
  • Thornburg Investment Management sold 19,924 Insmed shares in Q2 2026, an estimated $2.41M.
  • Insmed made up 0.02% of Thornburg Investment Management's portfolio in Q2 2026, its #119 holding.
  • Thornburg Investment Management first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • Thornburg Investment Management's Insmed position peaked at $6.61M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Thornburg Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.